BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:55:00 PM | Browse: 902 | Download: 1091
 |
Received |
|
2013-01-18 08:38 |
 |
Peer-Review Started |
|
2013-01-18 19:38 |
 |
To Make the First Decision |
|
2013-02-21 18:40 |
 |
Return for Revision |
|
2013-02-25 15:55 |
 |
Revised |
|
|
 |
Second Decision |
|
2013-04-28 14:29 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-04-29 01:10 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-06-04 17:41 |
 |
Publish the Manuscript Online |
|
2013-06-20 16:34 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Editorial |
Article Title |
Microscopic colitis: A therapeutic challenge
|
Manuscript Source |
Invited Manuscript |
All Author List |
Mario Guslandi |
Funding Agency and Grant Number |
|
Corresponding Author |
Mario Guslandi, MD, FACG, Professor, Gastroenterology Unit, S. Raffaele University Hospital, Via Olgettina 60, 20132 Milan, Italy. guslandi.mario@hsr.it |
Key Words |
Microscopic colitis; Budesonide; Mesalazine; Immunosuppressants |
Core Tip |
The efficacy of short-term treatment of microscopic colitis with budesonide is confirmed. Long-term therapy is not advisable because of possible side effects, but the efficacy of alternative drugs such as immunosuppressants or anti-tumor necrosis factor agents remains to be established. For the time being prolonged budesonide treatment in minimal doses, tailored on the single patient, appears to be the most sensible option. |
Publish Date |
2013-06-20 16:34 |
Citation |
Guslandi M. Microscopic colitis: A therapeutic challenge. World J Gastroenterol 2013; 19(23): 3531-3533 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i23/3531.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i23.3531 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345